Who owns the patient, the brand or the injector?
Med spa value hinges on a question that barely exists in other industries: if the lead provider left tomorrow, how many patients would follow? When the owner is the injector everyone books with, the practice is really a high-earning job, and buyers price it as one, low end of the range, heavy earnout, seller expected to stay. When there is a bench of providers, a recognizable clinic brand, and patients loyal to the practice rather than the person, the same revenue is worth materially more. Advisors consistently name owner/provider concentration as the single largest adjustment in medical-aesthetic valuations, worth on the order of a full turn once credible succession exists.
What buyers check first
- Provider concentration. Share of revenue tied to the owner personally, the top valuation lever.
- Recurring / membership revenue. Memberships, prepaid packages, and loyal repeat patients smooth cash flow and lift the multiple.
- Service and payer mix. Injectables (Botox, filler) vs. devices/lasers vs. wellness; recurring consumable-driven revenue is stickier.
- Medical director and compliance. Ownership structure, supervision, and licensing must transfer cleanly, a regulatory gap can break a deal.
The med spa question buyers ask first isn't how much it earns, it's how much of that earning would follow the injector out the door.
Why the range is so wide
Medical aesthetics is young, fragmented, and consolidating fast, so there is no single clean marketplace benchmark the way there is for laundromats or restaurants. Multiples reported by advisors vary with scale, service mix, membership depth, and buyer type (individual vs. strategic vs. PE platform), which is exactly why we present ranges rather than a precise figure. High-membership practices with prepaid packages and loyal patient bases are cited trading roughly half a turn to a full turn above single-visit-driven practices at the same revenue. Anyone valuing a specific med spa should lean on a sector advisor and recent, comparable transactions rather than a headline number.
Ranges, not a benchmark
Med spa data is dispersed and moving quickly. Use these bands to sanity-check, but price a real practice off recent comparable deals and its provider-dependence profile, not a single multiple.
Sources
- SovDoc, How to Value a Med Spa: 2025 Guide
- Sofer Advisors, Medical Spa Valuation Multiples & Add-Backs
- Breakwater M&A, Medical Spa Valuation Multiples 2026
- CT Acquisitions, Med Spa M&A Multiples Report 2026
Med Spa valuation multiples, FAQ
It depends heavily on scale and key-person risk. Sub-scale single sites run about 2×, 4× SDE, profitable single locations about 3.5×, 6× SDE (≈ 4×, 7× EBITDA), and multi-location platforms 6×, 9× EBITDA. Because the market is fragmented and fast-moving, these are defensible ranges rather than one precise benchmark.
Because value depends on how much of it is tied to the owner-provider. A practice where patients book specifically with the owner is priced like a job; one with a provider bench, a clinic brand, and membership revenue is priced like a business. Scale, service mix, and buyer type widen the range further, which is why we quote bands rather than a single figure.
Reducing provider concentration, building a bench so value doesn’t leave with one injector, is the biggest lever, worth roughly a full turn once credible succession exists. Membership and prepaid-package revenue, a loyal repeat patient base, a recurring-consumable service mix, and clean medical-director and compliance structure all add to the multiple.
Keep going
Compare every sector on the industry multiples hub, learn the buy playbook in our how to buy a med spa business guide, price a specific deal with the valuation calculator, and see the broader market in our SMB statistics.
Put a real number on a real deal
Drop in SDE and an asking price, our calculator returns a value range and a financing check in seconds.
